Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Larsen

Showing results (101-110 of 814) with videos related to

Pageof 82
Sort By:
European Journal of Neurology|December 4, 2008
The long-term functional status in patients with Guillain-Barré syndromeT Rudolph, J P Larsen, E Farbu
Acta Neurologica Scandinavica. Supplementum|July 1, 2010
Are dysautonomic and sensory symptoms present in early Parkinson's disease?O-B Tysnes, B Müller, J P Larsen
British Journal of Pharmacology|October 1, 2010
Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channelsA P Larsen, B H Bentzen, M Grunnet
The Journal of the American Osteopathic Association|February 1, 1989
Naloxone alteration of blood flow in a nonischemic region of the partially ischemic gerbil brainD F Brown, S P Larsen, C Parsa
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 18, 2007
Alloimmunity: no toll exemptionS Gangappa, C P Larsen, T C Pearson
Neurology|November 24, 2004
Is fatigue an independent and persistent symptom in patients with Parkinson disease?G Alves, T Wentzel-Larsen, J P Larsen
European Journal of Neurology|August 24, 1999
Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study GroupJ P Larsen, J Boas, J E Erdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 20, 1988
[Nursing homes patients with Parkinson disease: treatment]J P Larsen, E G Nessler, R Strandjord
Neurology|May 30, 2002
Development of daytime somnolence over time in Parkinson's diseaseM D Gjerstad, D Aarsland, J P Larsen
International Journal of Geriatric Psychiatry|March 10, 2001
Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's diseaseD Aarsland, J L Cummings, J P Larsen
Pageof 82

Showing results (101-110 of 814) with videos related to

Sort By:
Pageof 82
European Journal of Neurology|December 4, 2008
The long-term functional status in patients with Guillain-Barré syndromeT Rudolph, J P Larsen, E Farbu
Acta Neurologica Scandinavica. Supplementum|July 1, 2010
Are dysautonomic and sensory symptoms present in early Parkinson's disease?O-B Tysnes, B Müller, J P Larsen
British Journal of Pharmacology|October 1, 2010
Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a/Kv11.1b channelsA P Larsen, B H Bentzen, M Grunnet
The Journal of the American Osteopathic Association|February 1, 1989
Naloxone alteration of blood flow in a nonischemic region of the partially ischemic gerbil brainD F Brown, S P Larsen, C Parsa
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 18, 2007
Alloimmunity: no toll exemptionS Gangappa, C P Larsen, T C Pearson
Neurology|November 24, 2004
Is fatigue an independent and persistent symptom in patients with Parkinson disease?G Alves, T Wentzel-Larsen, J P Larsen
European Journal of Neurology|August 24, 1999
Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study GroupJ P Larsen, J Boas, J E Erdal
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 20, 1988
[Nursing homes patients with Parkinson disease: treatment]J P Larsen, E G Nessler, R Strandjord
Neurology|May 30, 2002
Development of daytime somnolence over time in Parkinson's diseaseM D Gjerstad, D Aarsland, J P Larsen
International Journal of Geriatric Psychiatry|March 10, 2001
Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's diseaseD Aarsland, J L Cummings, J P Larsen
Pageof 82